William Blair's Rating of Pyxis Oncology on 11/20/2026

On November 20, 2026, William Blair updated its outlook on Pyxis Oncology (NASDAQ:PYXS) with the action "Upgrade", setting a "Outperform" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from William Blair

DateCompanyAction
11/20/2026
Tesla, Inc. stock logo
TSLA
Tesla
Initiated Coverage
11/20/2026
Globant S.A. stock logo
GLOB
Globant
Reiterated Rating
11/20/2026
Anthropic PBC stock logo
ANT
Anthropic PBC
Initiated Coverage
11/19/2026
Owlet, Inc. stock logo
OWLT
Owlet
Reiterated Rating
11/19/2026
HAWK
HawkEye 360
Reiterated Rating
11/16/2026
Humana Inc. stock logo
HUM
Humana
Initiated Coverage
More Ratings From William Blair